Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Survival of Lactobacillus casei strain Shirota in the intestines of healthy Chinese adults

  • 2015-05
  • Microbiology and Immunology 59(5)
    • Ran Wang
    • Shanbin Chen
    • Junhua Jin
    • F. Ren
    • Yang Li
    • Zhenxing Qiao
    • Yue Wang
    • Liang Zhao

Abstract

Lactobacillus casei strain Shirota (LcS) is a widely used probiotic strain with health benefits. In this study, the survival of LcS in the intestines of healthy Chinese adults was assessed and the effects of LcS on stool consistency, stool SCFAs and intestinal microbiota evaluated. Subjects consumed 100 mL per day of a probiotic beverage containing 1.0 × 10(8) CFU/mL of LcS for 14 days. LcS were enumerated using a culture method and the colony identity confirmed by ELISA. Fourteen days after ingestion, the amount of LcS recovered from fecal samples was between 6.86 ± 0.80 and 7.17 ± 0.57 Log10 CFU/g of feces (mean ± SD). The intestinal microbiotas were analyzed by denaturing gradient gel electrophoresis. Principal component analysis showed that consuming LcS significantly changed fecal microbiota profiles. According to redundancy analysis, the amounts of 25 bacterial strains were significantly correlated with LcS intake (P < 0.05), 11 of them positively and fourteen negatively. Concentrations of acetic acid and propionic acid in feces were significantly lower during the ingestion period than during the baseline period (P < 0.05). These results confirm that LcS can survive passage through the gastrointestinal tract of Chinese people; however, they were found to have little ability to persist once their consumption had ceased. Furthermore, consumption of probiotic beverages containing LcS can modulate the composition of the intestinal microbiota on a long-term basis, resulting in decreased concentrations of SCFAs in the gut.

Keywords: Chinese adults; intestinal microbiota; recovery of Lactobacillus casei strain Shirota; short-chain fatty acids.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus casei Lc-11Altered Fecal Microbiota ProfileNeutral
Moderate
Lactobacillus casei Lc-11Improved Survival of Lactobacillus casei Shirota in the IntestinesNeutral
Moderate
Lactobacillus casei Lc-11Inability to Persist Post-ConsumptionNeutral
Moderate
Lactobacillus casei Lc-11Reduced Short-Chain Fatty Acid Levels in FecesNeutral
Moderate
Back to top